GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Chemclin Diagnostics Co 688468.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

5.73

-0.69%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥332.7m

FY2017FY2025

Net income

CN¥44.4m

FY2017FY2025

Free cash flow

CN¥24.0m

FY2017FY2025

Shareholders' equity

CN¥1.41bn

FY2017FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueCN¥332.7mCN¥436.3mCN¥445.3mCN¥465.3mCN¥470.8mCN¥418.2mCN¥454.7mCN¥366.1mCN¥318.6m
Gross profitCN¥221.2mCN¥323.2mCN¥334.8mCN¥344.2mCN¥350.9mCN¥301.0mCN¥341.5mCN¥264.1mCN¥227.7m
Research and developmentCN¥73.3mCN¥75.8mCN¥65.8mCN¥68.9mCN¥67.3mCN¥56.4mCN¥56.4mCN¥50.9mCN¥32.2m
Operating incomeCN¥50.3mCN¥134.7mCN¥166.3mCN¥170.3mCN¥162.6mCN¥136.9mCN¥159.7m−CN¥412.4m−CN¥420.2m
Net incomeCN¥44.4mCN¥127.1mCN¥147.4mCN¥152.6mCN¥142.8mCN¥117.0mCN¥140.6m−CN¥424.2m−CN¥435.2m
Diluted earnings per share0.070.330.380.400.370.360.39-0.70-0.72

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsCN¥1.76bnCN¥1.83bnCN¥1.82bnCN¥1.59bnCN¥1.43bnCN¥1.01bnCN¥993.4mCN¥856.2mCN¥713.2m
Cash and short-term investments—CN¥909.3mCN¥918.7mCN¥985.1mCN¥924.6mCN¥553.4mCN¥583.2mCN¥77.2mCN¥159.9m
Total liabilitiesCN¥350.0mCN¥415.9mCN¥431.8mCN¥210.6mCN¥152.2mCN¥119.5mCN¥126.4mCN¥80.9mCN¥66.2m
DebtCN¥160.2mCN¥224.3mCN¥234.6mCN¥12.5mCN¥24.6mCN¥10.2m———
Shareholders' equityCN¥1.41bnCN¥1.42bnCN¥1.39bnCN¥1.38bnCN¥1.28bnCN¥887.4mCN¥867.0mCN¥775.4mCN¥647.1m
Shares outstanding605m387m391m383m388m324m359m605m605m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsCN¥93.9mCN¥168.0mCN¥173.1mCN¥244.6mCN¥188.9mCN¥152.0mCN¥201.3mCN¥147.7mCN¥133.5m
Capital spending−CN¥69.9m−CN¥107.5m−CN¥301.4m−CN¥125.3m−CN¥72.5m−CN¥83.3m−CN¥55.2m−CN¥48.5m−CN¥59.4m
Free cash flowCN¥24.0mCN¥60.5m−CN¥128.3mCN¥119.3mCN¥116.3mCN¥68.6mCN¥146.0mCN¥99.2mCN¥74.0m
Dividends paid−CN¥54.8m−CN¥53.3m−CN¥139.1m−CN¥68.2m—−CN¥100.0m−CN¥41.6m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥81.1mCN¥73.3mCN¥71.9mCN¥96.2mCN¥83.3mCN¥81.3mCN¥92.5mCN¥118.2m
Gross profitCN¥47.9mCN¥45.1mCN¥43.7mCN¥68.5mCN¥54.6mCN¥54.4mCN¥60.7mCN¥89.7m
Operating incomeCN¥6.8mCN¥6.8mCN¥4.3mCN¥18.3mCN¥13.1mCN¥14.6mCN¥6.6mCN¥43.2m
Net incomeCN¥6.6mCN¥9.0mCN¥2.8mCN¥17.2mCN¥9.8mCN¥14.5mCN¥14.9mCN¥35.5m
Diluted earnings per share0.010.010.000.030.020.020.040.09
Cash from operations———CN¥34.0mCN¥24.0mCN¥15.0m—CN¥60.0m
Capital spending−CN¥3.0m−CN¥9.0m−CN¥11.0m−CN¥9.0m−CN¥10.0m−CN¥38.0m−CN¥11.0m−CN¥18.0m
Free cash flow———CN¥25.0mCN¥14.0m−CN¥23.0m—CN¥42.0m
Total assetsCN¥1.77bnCN¥1.76bnCN¥1.76bnCN¥1.77bnCN¥1.77bnCN¥1.82bnCN¥1.83bnCN¥1.84bn
Cash and short-term investments———CN¥863.4mCN¥853.7mCN¥887.2mCN¥909.3mCN¥889.7m
DebtCN¥160.2mCN¥160.2mCN¥160.2mCN¥26.7mCN¥200.2mCN¥200.2mCN¥200.2mCN¥220.4m
Shareholders' equityCN¥1.43bnCN¥1.42bnCN¥1.41bnCN¥1.41bnCN¥1.39bnCN¥1.43bnCN¥1.42bnCN¥1.40bn

Financial ratios

Data as of 24 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin66.5%74.1%75.2%74.0%74.5%72.0%
Operating margin16.9%32.8%37.4%38.2%34.6%32.4%
Net margin13.3%29.1%33.1%32.8%30.3%28.0%
Return on equity3.1%9.0%10.6%11.1%11.2%13.2%
Return on assets2.5%6.9%8.1%9.6%10.0%11.6%
Free cash flow yield4.5%11.8%20.2%16.1%11.2%12.1%
Revenue growth-23.7%-2.0%-4.3%-1.2%12.6%-8.0%
Earnings growth-65.1%-13.8%-3.4%6.9%22.0%-16.8%
Current ratio4.77x5.82x5.68x5.91x8.98x6.71x
Debt to equity0.11x0.14x0.15x0.01x0.01x0.00x
Equity ratio80.1%77.3%76.3%86.8%89.4%88.1%
Interest coverage8.77x26.90x269.37x295.49x206.39x1593.23x
R&D as a share of sales22.0%17.4%14.8%14.8%14.3%13.5%
Buybacks as a share of market value-56.5%1.0%-2.0%1.3%-19.8%9.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-10.6%-4.5%—
Operating income-33.4%-18.1%—
Net income-33.7%-17.6%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin70.8%72.8%73.0%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings100.020.928.623.848.7
Price to sales13.36.19.57.814.8

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 13 Jun 2025.

FY2025FY2024FY2023FY2022
Paid in the year0.1250.1250.3470.17

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.